A detailed history of Core Cap Advisors, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 2 shares of TXG stock, worth $30. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$30
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$19.45 - $37.37 $38 - $74
2 New
2 $0
Q4 2022

Feb 10, 2023

BUY
$24.4 - $41.3 $97 - $165
4 New
4 $0
Q2 2022

Aug 11, 2022

BUY
$36.95 - $82.41 $147 - $329
4 New
4 $0
Q1 2022

Apr 29, 2022

SELL
$55.7 - $145.79 $278 - $728
-5 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$135.05 - $182.59 $675 - $912
5 New
5 $1,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.47B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.